| SOCS1基因修饰树突状细胞在肿瘤治疗中的研究进展 |
| |
| 引用本文： | 远洋,王雪峰,李云霞,穆兰,潘欣宇.SOCS1基因修饰树突状细胞在肿瘤治疗中的研究进展[J].生命科学,2011(5):482-486. |
| |
| 作者姓名： | 远洋 王雪峰 李云霞 穆兰 潘欣宇 |
| |
| 作者单位： | 辽宁医学院;辽宁医学院附属第一医院; |
| |
| 基金项目： | 辽宁省自然科学基金项目(20082180) |
| |
| 摘 要： | 树突状细胞是功能最强的抗原提呈细胞,是启动、调节及维持免疫应答的核心环节,以树突状细胞为基础的肿瘤疫苗被认为是最具潜能的肿瘤免疫治疗手段。细胞因子信号通路抑制因子1（suppressor ofcytokine signaling1,SOCS1）是细胞因子信号通路抑制因子（suppressor of cytokine signaling,SOCS）家族的重要成员,广泛参与树突状细胞的发生、成熟和活化,具有负调控树突状细胞功能的重要作用。SOCS1沉默的树突状细胞能够促进自身成熟并增强其诱导的T细胞的抗肿瘤活性。现就国内外关于树突状细胞功能研究及基因修饰的肿瘤疫苗临床试验作一综述,以期对未来的研究有所帮助。
|
| 关 键 词： | 细胞因子信号转导抑制因子1 树突状细胞疫苗 肿瘤治疗 |
Progress of study on SOCS1 silent DC vaccine for oncotherapy |
| |
| YUAN Yang,WANG Xue-Feng,LI Yun-Xia,MU Lan,PAN Xin-Yu.Progress of study on SOCS1 silent DC vaccine for oncotherapy[J].Chinese Bulletin of Life Sciences,2011(5):482-486. |
| |
| Authors: | YUAN Yang WANG Xue-Feng LI Yun-Xia MU Lan PAN Xin-Yu |
| |
| Institution: | YUAN Yang1,WANG Xue-Feng2*,LI Yun-Xia1,MU Lan1,PAN Xin-Yu1(1 Liaoning Medical University,Jinzhou 121001,China,2 Department of Otolaryngology,The First Affiliated Hospital of Liaoning Medical University,China) |
| |
| Abstract: | Dendritic cell is the most potent professional antigen-presenting cell,which displays an extraordinary capacity to induce,sustain and regulate immune responses.For this reason,DC vaccine is considered the most potential tumor immune therapy.Suppressor of cytokine signaling 1(SOCS1) is an important member of SOCS family,which is irreplaceable in the regulation of DC activation,development,and differentiation.SOCS1 represents an inhibitory control mechanism for DC antigen presentation.SOCS1 silent DC could pr... |
| |
| Keywords: | suppressor of cytokine signaling 1 DC vaccine oncotherapy |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
